However, it has been well-defined that the aberrant tyrosine kinase activity by EGFR has a close relation with tumorigenesis in a variety of cancer types such as lung, colon, and breast cancers (Corkery et al., 2009; Efferth, 2012; Quan et al., 2018). This evidence concerns the gene EGFR and breast carcinoma.